Alpha 2.0
Login Register
» Authors » Andrea Marmiroli

Andrea Marmiroli

Explore the profile of Andrea Marmiroli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 33
Followers 0
Related Specialties
Urology
Oncology
Top 10 Co-Authors
Markus Graefen
Mattia Longoni
Fred Saad
Quynh Chi Le
Alberto Briganti
Natali Rodriguez Penaranda
Fabian Falkenbach
Pierre I Karakiewicz
Zhe Tian
Shahrokh F Shariat
Published In
World J Urol
Urol Oncol
Clin Genitourin Cancer
Ann Surg Oncol
Cancers (Basel)
Affiliations
Soon will be listed here.
Recent Articles
11.
Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History Patients
Falkenbach F, Di Bello F, Penaranda N, Longoni M, Marmiroli A, Le Q, et al.
Cancers (Basel) . 2024 Aug; 16(15). PMID: 39123490
Introduction: Leukemia history affects some radical prostatectomy (RP) patients. Although its prevalence and effect as an adverse risk factor are well known in cardiac surgery, the number of RP patients...
12.
Vacuum-assisted mini-percutaneous nephrolithotomy is associated with lower rates of infectious complications compared to vacuum-cleaner procedure in patients at high risk for infections: a single-center experience
Marmiroli A, Nizzardo M, Zanetti S, Lucignani G, Turetti M, Silvani C, et al.
World J Urol . 2024 Mar; 42(1):200. PMID: 38536503
Purpose: To evaluate the impact of vacuum-assisted mini-percutaneous nephrolithotomy (vamPCNL) vs. vacuum-cleaner mPCNL (vcmPCNL) on the rate of postoperative infectious complications in a cohort of patients with high risk factors...
13.
Transient ureteral obstruction after mini-percutaneous nephrolithotomy is associated with stone volume and location: results from a single-center, real-life study
Nizzardo M, Zanetti S, Marmiroli A, Lucignani G, Turetti M, Silvani C, et al.
World J Urol . 2024 Mar; 42(1):146. PMID: 38478085
Purpose: To evaluate the rate of and predictors of ureteral obstruction after mini-percutaneous nephrolithotomy (mPCNL) for kidney stones. Methods: We analyzed data from 263 consecutive patients who underwent mPCNL at...
14.
Prevalence and predictors of stone passage after double J stenting for symptomatic ureteral stones: a cross-sectional, real-life study
Nogara A, Lucignani G, Turetti M, Silvani C, Marmiroli A, Nizzardo M, et al.
World J Urol . 2024 Jan; 42(1):8. PMID: 38180579
Purpose: To evaluate the rate of and predictors of stone passage (SP) after urgent retrograde stenting for symptomatic ureteral stones. Methods: We retrospectively analysed data from 249 consecutive patients presenting...
15.
Perioperative and Survival Outcomes of Patients Treated With Robot-Assisted Partial Nephrectomy and Percutaneous Microwave Ablation for Small Renal Masses: A Single Center Experience
Lucignani G, De Lorenzis E, Ierardi A, Silvani C, Marmiroli A, Nizzardo M, et al.
Clin Genitourin Cancer . 2023 Dec; 22(2):237-243. PMID: 38065718
Background: Robot assisted partial nephrectomy (RAPN) and microwave ablation (MWA) are 2 of the most advanced techniques for the management of localized small renal masses. Purpose: To compare the perioperative,...
16.
Thermal ablation for small renal masses: Identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes
Luzzago S, Mistretta F, Mauri G, Vaccaro C, Ghilardi G, Maiettini D, et al.
Urol Oncol . 2022 Oct; 40(12):537.e1-537.e9. PMID: 36224057
Objectives: To test TRIFECTA achievement [1) absence of CLAVIEN-DINDO ≥3 complications; 2) complete ablation; 3) absence of ≥30% decrease in eGFR] and local recurrence rates, according to tumor size, in...
17.
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer
Ferro M, Barone B, Crocetto F, Lucarelli G, Busetto G, Del Giudice F, et al.
Urol Oncol . 2022 Jun; 40(11):490.e13-490.e20. PMID: 35676172
Introduction: Seventy-five percent of bladder cancers are non-muscle invasive. The treatment strategy includes the transurethral resection of bladder tumor (TURB) followed by intravesical immunotherapy with the bacillus of Calmette-Guerin (BCG)...